Hoosier Vapor’s Tiffany Jones talks about CBD oil. Kelly Wilkinson/IndyStar
This is one of the CBD products for sale at Hoosier Vapor in Plainfield, seen Thursday, Nov. 30, 2017. The store, which sells CBD oil products will likely pull the products in accordance with an order from the governor. Tiffany Jones, whose family owns the stores, has started an online petition in protest of that decision and has garnered more than 21,000 signatures in eight days. For now, they have all the products on clearance at their stores.(Photo: Kelly Wilkinson/IndyStar)Buy Photo
At Hoosier Vapor stores, many customers come in search of an oil that they hope can treat a range of maladies from insomnia to pain to migraines to gastrointestinal issues to arthritis.
Since the three stores started carrying cannabidiol, or CBD, oil about a year and a half ago, the products have become their second best-sellers, right after vape juice. Soon, however, the stores may have to take these products off their shelves.
While advocates continue to push for CBD legalization, some medical scientists question whether the compound even provides the broad spectrum of medical benefits users espouse.
Medical science reaches conclusions about a product’s safety and efficacy based on studies and few of those have been done on CBD – at least not the randomized double-blind placebo trials in humans that constitute the gold standard. Hard-to-treat epilepsy is the one area where scientists agree the research shows CBD can work.
All those other conditions?
“I don’t think there are true scientific studies that are really rigorous scientific studies that would demonstrate a clear benefit or not in other disease states,” said Timothy Welty, professor and chair of the clinical sciences department at the College